WHO - Advanced Technical Briefing Seminar (TBS) on Quality & Safety
ðÅÒÅ×ÏÄ ÉÚ E-drug: ôÅÈÎÉÞÅÓËÉÊ óÅÍÉÎÁÒ-âÒÉÆÉÎÇ ÷ïú ÐÏ ËÁÞÅÓÔ×Õ É ÂÅÚÏÐÁÓÎÏÓÔÉ ÌÅËÁÒÓÔ×
ðÅÒÅ×ÏÄ: úÉÇÁÎÛÉÎÁ ìÉÌÉÑ å×ÇÅÎØÅ×ÎÁ, ëÁÚÁÎÓËÉÊ æÅÄÅÒÁÌØÎÙÊ õÎÉ×ÅÒÓÉÔÅÔ
---------------------------------------------------------------------------
äÅÐÁÒÔÁÍÅÎÔ ïÓÎÏ×ÎÙÈ ìÅËÁÒÓÔ× É æÁÒÍÁÃÅ×ÔÉÞÅÓËÏÊ ðÏÌÉÔÉËÉ ÷ÓÅÍÉÒÎÏÊ ïÒÇÁÎÉÚÁÃÉÉ úÄÒÁ×ÏÏÈÒÁÎÅÎÉÑ ÐÒÏ×ÏÄÉÔ ôÅÈÎÉÞÅÓËÉÊ óÅÍÉÎÁÒ-âÒÉÆÉÎÇ ÐÏ ËÁÞÅÓÔ×Õ É ÂÅÚÏÐÁÓÎÏÓÔÉ ÌÅËÁÒÓÔ× 12-16 óÅÎÔÑÂÒÑ 2011, × ÛÔÁÂ-Ë×ÁÒÔÉÒÅ ÷ïú, × öÅÎÅ×Å (û×ÅÊÃÁÒÉÑ).
çÅÎÅÒÁÌØÎÁÑ ÃÅÌØ ÜÔÏÇÏ óÅÍÉÎÁÒÁ - ÓÔÉÍÕÌÉÒÏ×ÁÔØ ÓÏÔÒÕÄÎÉÞÅÓÔ×Ï ÷ïú É ÄÒÕÇÉÈ ÉÇÒÏËÏ× (ÓÔÅÊËÈÏÌÄÅÒÏ× - ÚÁÉÎÔÅÒÅÓÏ×ÁÎÎÙÈ ÇÒÕÐÐ) ÉÚ ÐÒÁ×ÉÔÅÌØÓÔ×ÅÎÎÙÈ É ÎÅÐÒÁ×ÉÔÅÌØÓÔ×ÅÎÎÙÈ ÏÒÇÁÎÉÚÁÃÉÊ, ÕÞÁÓÔ×ÕÀÝÉÈ × ÂÏÒØÂÅ ÚÁ ËÁÞÅÓÔ×Ï É ÂÅÚÏÐÁÓÎÏÓÔØ ÌÅËÁÒÓÔ× ÎÁ ÇÌÏÂÁÌØÎÏÍ ÕÒÏ×ÎÅ.
ðÒÏÇÒÁÍÍÁ ÂÙÌÁ ÒÁÚÒÁÂÏÔÁÎÁ ÔÁËÉÍ ÏÂÒÁÚÏÍ, ÞÔÏÂÙ ÐÏ×ÙÓÉÔØ ÏÓ×ÅÄÏÍÌÅÎÎÏÓÔØ É ÚÎÁÎÉÑ ÐÏ ×ÏÒÏÓÁÍ ÏÂÅÓÐÅÞÅÎÉÑ ËÁÞÅÓÔ×Á É ÂÅÚÏÐÁÓÎÏÓÔÉ ÌÅËÁÒÓÔ×, ÐÒÏÄÕËÔÏ× ËÒÏ×É É ÄÒÕÇÉÈ ÂÉÏÌÏÇÉÞÅÓËÉÈ ÓÒÅÄÓÔ×, Ó ÏÓÏÂÅÎÎÙÍ ÆÏËÕÓÏÍ ÎÁ ÐÒÏÃÅÓÓÙ, ÓÔÁÄÁÒÔÙ ËÏÔÏÒÙÈ ÏÐÒÅÄÅÌÑÀÔÓÑ ÷ïú.
ðÒÅÚÅÎÔÁÃÉÉ, ÂÒÉÆÉÎÇÉ É ÔÅÍÙ ÄÌÑ ÄÉÓËÕÓÓÉÊ ÂÕÄÕÔ ×ËÌÀÞÁÔØ:
- òÁÚÒÁÂÏÔËÁ ÷ïú ÒÕËÏ×ÏÄÓÔ×, ÆÁÒÍÁËÏÐÅÊÎÙÈ ÓÔÁÔÅÊ É ÉÎÆÏÒÍÁÃÉÏÎÎÙÈ ÒÅÓÕÒÓÏ×;
- óÏÔÒÕÄÎÉÞÁÀÝÉÅ ÐÏÄÈÏÄÙ Ë ËÌÁÓÓÉÆÉËÁÃÉÏÎÎÙÍ ÓÉÓÔÅÍÁÍ (íÅÖÄÕÎÁÒÏÄÎÙÅ ÎÅÐÁÔÅÎÔÏ×ÁÎÎÙÅ ÎÁÉÍÅÎÏ×ÁÎÉÑ, áÎÁÔÏÍÉÞÅÓËÁÑ-ôÅÒÁÐÅ×ÔÉÞÅÓËÁÑ-èÉÍÉÞÅÓËÁÑ (áôè) ËÌÁÓÓÉÆÉËÁÃÉÑ);
- ïÂÅÓÐÅÞÅÎÉÅ ËÁÞÅÓÔ×Á ÌÅËÁÒÓÔ×, ÐÒÏÄÕËÔÏ× ËÒÏ×É É ÒÏÄÓÔ×ÅÎÎÙÈ ÂÉÏÌÏÇÉÞÅÓËÉÈ ÓÒÅÄÓÔ×;
- äÅÑÔÅÌØÎÏÓÔØ ÐÒÏÅËÔÁ ÐÒÅË×ÁÌÉÆÉËÁÃÉÉ ÷ïú;
- çÌÏÂÁÌØÎÁÑ ÐÒÏÇÒÁÍÍÁ ÆÁÒÍÁËÏÂÄÉÔÅÌØÎÏÓÔÉ ÷ïú;
- ÷ËÌÁÄ ÷ïú × ÍÅÖÄÕÎÁÒÏÄÎÙÊ ËÏÎÔÒÏÌØ ÎÁÒËÏÔÉËÏ× É ÐÓÉÈÏÔÒÏÐÎÙÈ ×ÅÝÅÓÔ×.
ôÅÈÎÉÞÅÓËÉÊ ÓÅÍÉÎÁÒ-ÂÒÉÆÉÎÇ ÂÕÄÅÔ ÉÎÔÅÒÅÓÅÎ ÔÅÈÎÉÞÅÓËÉÍ ÓÐÅÃÉÁÌÉÓÔÁÍ, ÐÒÅÄÓÔÁ×ÉÔÅÌÑÍ ÷ïú, ÒÅÇÉÏÎÁÌØÎÙÍ ÓÏ×ÅÔÎÉËÁÍ É ÓÏÔÒÕÄÎÉËÁÍ ÓÔÒÁÎÏ×ÙÈ ÏÆÉÓÏ× ÷ïú É ÄÒÕÇÉÈ ÁÇÅÎÔÓÔ× ïïî, ÓÏÔÒÕÄÎÉËÁÍ ÎÁÃÉÏÎÁÌØÎÙÈ É ÒÅÇÉÏÎÁÌØÎÙÈ ÒÅÇÕÌÑÔÏÒÎÙÈ ÁÇÅÎÔÓÔ×, É ÏÆÉÃÉÁÌØÎÙÍ ÌÉÃÁÍ ÐÒÁ×ÉÔÅÌØÓÔ× É ÎÅÐÒÁ×ÉÔÅÌØÓÔ×ÅÎÎÙÈ ÏÒÇÁÎÉÚÁÃÉÊ, ÒÁÂÏÔÁÀÝÉÈ × ÓÍÅÖÎÙÈ ÏÂÌÁÓÔÑÈ.
þÉÓÌÏ ÕÞÁÓÔÎÉËÏ× ÏÇÒÁÎÉÞÅÎÏ - 25 ÞÅÌÏ×ÅË. õÞÁÓÔÉÅ - ÂÅÓÐÌÁÔÎÏ. ïÄÎÁËÏ, ËÁÖÄÙÊ ÕÞÁÓÔÎÉË ÓÁÍÏÓÔÏÑÔÅÌØÎÏ ÎÅÓÅÔ ÏÔ×ÅÔÓÔ×ÅÎÎÏÓÔØ ÚÁ Ó×ÏÉ ÔÒÁÎÓÐÏÒÔÎÙÅ ÒÁÓÈÏÄÙ É ÐÒÏÖÉ×ÁÎÉÅ. ðÏÓÌÅÄÎÉÊ ÄÅÎØ ÐÏÄÁÞÉ ÚÁÑ×ÌÅÎÉÊ - 30 ÉÀÎÑ 2011 ÇÏÄÁ. úÁÉÎÔÅÒÅÓÏ×ÁÎÎÙÅ ÌÉÃÁ ÍÏÇÕÔ ÐÏÄÁ×ÁÔØ ÚÁÑ×ÌÅÎÉÑ × ÜÌÅËÔÒÏÎÎÏÊ ÆÏÒÍÅ, ËÏÔÏÒÕÀ ÍÏÖÎÏ ÐÏÌÕÞÉÔØ ÎÁ ÓÁÊÔÅ: http://www.who.int/medicines/technical_briefing/quality/en/index.html
Samvel Azatyan M.D., Ph.D. | Manager, Medicines Regulatory Support Programme [MRS]
Quality Assurance and Safety: Medicines
Department of Essential Medicines and Pharmaceutical Policies (EMP)
World Health Organization
20, Avenue Appia, CH-1211, Geneva 27, Switzerland
Direct phone: +41 22 791 1506 | Fax: +4122 791 4167
E-mail: azatyans@who.int <mailto:azatyans@who.int>
Skype: WHOHQGVA1 - then dial 11506
BlackBerry PIN: 2206EB6D
http://www.who.int/medicines/en/
E-drug: WHO - Advanced Technical Briefing Seminar (TBS) on Quality & Safety
---------------------------------------------------------------------------
The Department of Essential Medicines and Pharmaceutical Policies(HSS/EMP) of the World Health Organization will organize an Advanced Technical Briefing Seminar (TBS) on Quality and Safety of Medicines, to be held from 12-16 September 2001, at the WHO Headquarters in Geneva, Switzerland.
The general objective of this Seminar is to advance collaboration between WHO and other stakeholders from governmental and non-governmental organizations engaged in promoting the quality and safety of medicines in the global community.
The programme has been developed to increase awareness and knowledge of quality assurance and safety of medicines, blood products and related biologicals with a special focus on WHO standard-setting processes. Presentations, briefing and discussion topics will include :
* WHO development of guidelines, pharmacopoeial monographs and information resources;
* collaborative approaches underpinning classification systems (International nonproprietary names, Anatomical Therapeutic Chemical (ATC) Classification;
* quality assurance of medicines, blood products and related biologicals;
* WHO prequalification project activities;
* WHO global pharmacovigilance programme;
* WHO input to international control of narcotic and psychotropic substances
The technical briefing will be of interest to technical officers, WHO Representatives, regional advisers and country office staff of WHO and other UN agencies, national and regional drug regulators, and government and non-government officials working in related areas.
Attendance is limited to 25 places. Participation is free of charge. However, each participant is responsible for own travel and accommodation costs.
The closing date for the submission of applications is 30 June 2011. Interested persons can apply using the electronic application form, which is available at: http://www.who.int/medicines/technical_briefing/quality/en/index.html
Samvel Azatyan M.D., Ph.D. | Manager, Medicines Regulatory Support Programme [MRS]
Quality Assurance and Safety: Medicines
Department of Essential Medicines and Pharmaceutical Policies (EMP)
World Health Organization
20, Avenue Appia, CH-1211, Geneva 27, Switzerland
Direct phone: +41 22 791 1506 | Fax: +4122 791 4167
E-mail: azatyans@who.int <mailto:azatyans@who.int>
Skype: WHOHQGVA1 - then dial 11506
BlackBerry PIN: 2206EB6D
http://www.who.int/medicines/en/